BR0008006A - Métodos e composições para uso em aplicações deperfusão - Google Patents

Métodos e composições para uso em aplicações deperfusão

Info

Publication number
BR0008006A
BR0008006A BR0008006-3A BR0008006A BR0008006A BR 0008006 A BR0008006 A BR 0008006A BR 0008006 A BR0008006 A BR 0008006A BR 0008006 A BR0008006 A BR 0008006A
Authority
BR
Brazil
Prior art keywords
compositions
methods
fluid
applications
composition
Prior art date
Application number
BR0008006-3A
Other languages
English (en)
Inventor
Paul E Segall
Harold D Watz
Hal Sternberg
Original Assignee
Biotime Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotime Inc filed Critical Biotime Inc
Publication of BR0008006A publication Critical patent/BR0008006A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • External Artificial Organs (AREA)

Abstract

Patente de Invenção: "MéTODOS E COMPOSIçõES PARA USOEM APLICAçõES DE PERFUSãO". Métodos e composições parauso em aplicações de perfusão são fornecidos. Nos métodosobjetos, um sujeito ou um derivado deste, por exemplo órgão outecido isolado, é infundido, perfundido e/ou transfundido com pelomenos duas composições fluidas. A primeira composição fluida éuma solução tipo plasma sem tampão biológico de ocorrência nãonatural e a segunda composição fluida é uma composição desangue fluida. Em uma modalidade preferida, um volume adicionalda primeira solução, ou um derivado do mesmo, é administrada aopaciente seguindo a introdução da composição fluida de sangue.São também fornecidos kits e sistemas para execução dosmétodos objetos. Os métodos e composições objetos encontramuso na variedade de aplicações de perfusão, incluíndo otratamento de aplicações cirúrgicas hipotérmicas, procedimentoscriogênicos, e outros.
BR0008006-3A 1999-02-03 2000-01-24 Métodos e composições para uso em aplicações deperfusão BR0008006A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/243,921 US6589223B1 (en) 1999-02-03 1999-02-03 Method and compositions for use in perfusion applications
PCT/US2000/001703 WO2000045873A1 (en) 1999-02-03 2000-01-24 Methods and compositions for use in perfusion applications

Publications (1)

Publication Number Publication Date
BR0008006A true BR0008006A (pt) 2001-12-04

Family

ID=22920663

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0008006-3A BR0008006A (pt) 1999-02-03 2000-01-24 Métodos e composições para uso em aplicações deperfusão

Country Status (14)

Country Link
US (3) US6589223B1 (pt)
EP (1) EP1150728A4 (pt)
JP (2) JP2002536078A (pt)
CN (1) CN1200742C (pt)
AR (1) AR022482A1 (pt)
AU (1) AU765144B2 (pt)
BR (1) BR0008006A (pt)
CA (1) CA2362051C (pt)
EA (1) EA003171B1 (pt)
IL (1) IL144710A0 (pt)
MX (1) MXPA01007875A (pt)
TW (1) TW542728B (pt)
WO (1) WO2000045873A1 (pt)
ZA (1) ZA200107243B (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8409846B2 (en) 1997-09-23 2013-04-02 The United States Of America As Represented By The Department Of Veteran Affairs Compositions, methods and devices for maintaining an organ
US6589223B1 (en) * 1999-02-03 2003-07-08 Biotime, Inc. Method and compositions for use in perfusion applications
US6718735B2 (en) * 2002-03-19 2004-04-13 Baxter International Inc. Albumin in a flexible polymeric container
US7354342B2 (en) * 2003-07-30 2008-04-08 Igt Gaming device having a multiple coordinate award distributor including award percentages
US8304181B2 (en) 2004-10-07 2012-11-06 Transmedics, Inc. Method for ex-vivo organ care and for using lactate as an indication of donor organ status
CA3178010A1 (en) * 2004-10-07 2006-04-20 Transmedics, Inc. Systems and methods for ex-vivo organ care
US12010987B2 (en) 2004-10-07 2024-06-18 Transmedics, Inc. Systems and methods for ex-vivo organ care and for using lactate as an indication of donor organ status
US9301519B2 (en) * 2004-10-07 2016-04-05 Transmedics, Inc. Systems and methods for ex-vivo organ care
EP1904151A4 (en) * 2005-06-22 2011-06-22 Univ Pittsburgh EMERGENCY RESERVE AND PRESERVATION METHODS
US9078428B2 (en) 2005-06-28 2015-07-14 Transmedics, Inc. Systems, methods, compositions and solutions for perfusing an organ
US8286159B2 (en) * 2005-12-22 2012-10-09 Alan Joshua Shapiro Method and apparatus for gryphing a data storage medium
CA2980782C (en) * 2006-04-19 2020-10-27 Transmedics, Inc. Systems and methods for ex vivo organ care
US9457179B2 (en) 2007-03-20 2016-10-04 Transmedics, Inc. Systems for monitoring and applying electrical currents in an organ perfusion system
CN101888846B (zh) * 2007-10-05 2013-02-27 国立大学法人千叶大学 稳定的含碳酸氢根离子的药物溶液
US20090123436A1 (en) * 2007-11-08 2009-05-14 Surmodics, Inc. Cryopreservative compositions and methods
US10750738B2 (en) * 2008-01-31 2020-08-25 Transmedics, Inc. Systems and methods for ex vivo lung care
SE534527C2 (sv) * 2009-09-24 2011-09-20 Vivoline Medical Ab Förfarande, anordning och vätska för behandling av ett hjärta efter uttagning
CN103841824B (zh) 2011-04-14 2016-12-14 特兰斯迈迪茨公司 用于供体肺的离体机器灌注的器官护理溶液
US8579880B2 (en) * 2012-03-01 2013-11-12 Outcome Solutions, Llc Devices and methods for making and administering an intravenous liquid with supersaturated dissolved gas
IL303658B2 (en) 2014-06-02 2024-07-01 Transmedics Inc Extracorporeal system for organ treatment
CA2970117A1 (en) 2014-12-12 2016-06-16 Darren FREED Apparatus and method for organ perfusion
ES2853027T3 (es) 2015-09-09 2021-09-14 Transmedics Inc Cánula aórtica para sistema de cuidado de órganos ex vivo
EP3462861B9 (en) 2016-05-30 2023-12-20 Transmedics, Inc. Method for ex vivo lung ventilation with a varying exterior pressure

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3677024A (en) 1970-01-20 1972-07-18 Paul E Segall Preservation and storage of biologic materials
US3937821A (en) 1971-08-21 1976-02-10 Kyorin Seiyaku Kabushiki Kaisha Plasma substitute including artificial starch and method for the preparation thereof
US4001401A (en) 1975-02-02 1977-01-04 Alza Corporation Blood substitute and blood plasma expander comprising polyhemoglobin
US4061736A (en) 1975-02-02 1977-12-06 Alza Corporation Pharmaceutically acceptable intramolecularly cross-linked, stromal-free hemoglobin
DE2801123C2 (de) 1977-01-26 1986-01-02 Armour Pharma GmbH & Co KG, 3440 Eschwege Verfahren zur Herstellung eines intravenös applizierbaren Serumeiweiß-Präparates
EP0185759B2 (en) 1984-06-22 2004-06-02 Btg International Limited Electrolyte solutions and (in vivo) use thereof
US5084377A (en) * 1984-09-19 1992-01-28 Larry Rowan Cryogenic suspension method
US4908350A (en) 1985-10-31 1990-03-13 The Regents Of The University Of California Hyperosmotic/hyperoncotic solutions for resuscitation of hypodynamic shock
US5210083A (en) * 1986-07-17 1993-05-11 Ed. Geistlich Sohne A.G. Fur Chemische Industrie Pharmaceutical compositions
JPS6360931A (ja) 1986-08-29 1988-03-17 Noboru Sato 血液または血液製剤保存液およびこれを用いた血液または血液製剤の保存方法
US4927806A (en) * 1987-04-23 1990-05-22 The Regents Of The University Of California Saturated salt/concentrated dextran formulation to treat hemorrhage
EP0397689B1 (en) * 1987-12-24 1994-05-11 BORODY, Thomas Julius Orthostatic lavage solutions
USRE34077E (en) * 1988-05-02 1992-09-22 Cryomedical Sciences, Inc. Blood substitute
US4923442A (en) * 1988-05-02 1990-05-08 Cryomedical Sciences Inc. Blood substitute
US5130230A (en) * 1988-05-02 1992-07-14 Cryomedical Sciences, Inc. Blood substitute
US5082831A (en) * 1989-12-05 1992-01-21 Cryovita Laboratories, Inc. Total body washout solution and method of use
US5171526A (en) * 1990-01-05 1992-12-15 Allergan, Inc. Ophthalmic compositions and methods for preserving and using same
CA2066374C (en) 1991-04-19 2002-01-29 Paul E. Segall Solution for perfusing primates
WO1993002653A1 (en) * 1991-08-08 1993-02-18 Segel Leigh D Fluorocarbon blood substitute
US5334142A (en) * 1991-09-09 1994-08-02 New York University Selective aortic perfusion system
US5374428A (en) * 1993-03-23 1994-12-20 Kansas State University Research Foundation Supplementation of protein diets with di- and tripeptides
US5407428A (en) * 1993-06-04 1995-04-18 Biotime, Inc. Solutions for use as plasma expanders and substitutes
US5702880A (en) 1993-06-04 1997-12-30 Biotime, Inc. Blood substitute comprising 0-5 mM K+
US5405742A (en) * 1993-07-16 1995-04-11 Cyromedical Sciences, Inc. Solutions for tissue preservation and bloodless surgery and methods using same
US6218099B1 (en) * 1994-06-03 2001-04-17 Biotime, Inc. Methods and compositions for use in perfusion applications
US5730720A (en) 1995-08-18 1998-03-24 Ip Scientific, Inc. Perfusion hyperthermia treatment system and method
US6589223B1 (en) * 1999-02-03 2003-07-08 Biotime, Inc. Method and compositions for use in perfusion applications

Also Published As

Publication number Publication date
US7503913B2 (en) 2009-03-17
TW542728B (en) 2003-07-21
MXPA01007875A (es) 2002-08-20
EA200100855A1 (ru) 2002-02-28
JP5180912B2 (ja) 2013-04-10
IL144710A0 (en) 2002-06-30
WO2000045873A1 (en) 2000-08-10
CA2362051A1 (en) 2000-08-10
AU765144B2 (en) 2003-09-11
JP2009242404A (ja) 2009-10-22
CA2362051C (en) 2010-06-29
CN1200742C (zh) 2005-05-11
EA003171B1 (ru) 2003-02-27
EP1150728A4 (en) 2004-09-29
US6589223B1 (en) 2003-07-08
US6991624B2 (en) 2006-01-31
AR022482A1 (es) 2002-09-04
ZA200107243B (en) 2002-09-02
US20040018966A1 (en) 2004-01-29
US20060088606A1 (en) 2006-04-27
AU3349700A (en) 2000-08-25
CN1346286A (zh) 2002-04-24
JP2002536078A (ja) 2002-10-29
EP1150728A1 (en) 2001-11-07

Similar Documents

Publication Publication Date Title
BR0008006A (pt) Métodos e composições para uso em aplicações deperfusão
Goodnough et al. Bloodless medicine: clinical care without allogeneic blood transfusion.
ATE375809T1 (de) Zugangsöffnung mit klip und verwendungsverfahren
BR0104817A (pt) Sistema de liberação transdérmica de drogas baseado em solução
BR9811825A (pt) Uso de lactobacillus para redução do nìvel de fibrinogênio no sangue
BR9810745A (pt) Derivados de benzimidazol
Sheldon et al. Cutaneous mucormycosis: two documented cases of suspected nosocomial cause
Sejourne et al. Effect of haemodilution on transfusion requirements in liver resection
BRPI0408439A (pt) composição farmacêutica lìquida aquosa, método para preparar e uso da mesma, método para tratar uma sìndrome responsiva ao fator vii, e, recipiente hermético
BR0110049A (pt) Agonista de cxcr4, uso de um agonista de cxcr4, e composição farmacêutica
KR940003564A (ko) 특정 질환의 예방 및 치료용 약제를 제조하기 위한 c1- 불활성제화제의 용도
TW200501932A (en) Sterile combined preparation and manufacture method thereof
Sealy Hypothermia: its possible role in cardiac surgery
De Falco et al. Intra-operative local plus systemic tranexamic acid significantly decreases post-operative bleeding and the need for allogeneic blood transfusion in total knee arthroplasty
KR960013383A (ko) 항혈전성 및 피브린용해성 치료제와 조합하여 사용되는 치료제로서의 폰 빌레브란트 인자(vWF)-함유 농축물의 용도
BRPI0410374A (pt) composição farmacêutica que compreende valsartano
HUP0401188A2 (hu) Hiperelágazásos amilopektin sebészeti, gyógyító vagy diagnosztikai eljárásokban emlősöknél való alkalmazásra, különösen plazmatérfogat-növelőként
Østergaard et al. Intra-articular corticosteroids in arthritic disease: a guide to treatment
BRPI0416461A (pt) método para o tratamento de episódios de sangramento, formulação farmacêutica, e, uso de um polipeptìdeo fxi
Galois et al. Autologous bone marrow graft and treatment of delayed and non-unions of long bones: technical aspects
CN106822090B (zh) 3,4,7-三羟基异黄酮或3-甲氧基大豆素在制备抑制血小板聚集和血栓药物中的应用
SATTERLEE et al. The use of herudin in the transfusion of blood
JP4752058B2 (ja) 肝再生用骨髄細胞画分
Wang et al. Effectiveness and safeties of hemocoagulase and tranexamic acid to reduce perioperative blood loss in intertrochanteric fracture PFNA fixation
BRPI0413032A (pt) diamidas de aminoacidos em uma posição não-(alfa), úteis como adjuvantes na administração de agentes biológicos ativos

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 10 (VIII), 11, 13 E 25 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.